Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Molecular Partners stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MOLN.
You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.
Other companies in Molecular Partners’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), 4D Molecular Therapeutics (NASDAQ:FDMT), Quoin Pharmaceuticals (NASDAQ:QNRX), Larimar Therapeutics (NASDAQ:LRMR) and Fate Therapeutics (NASDAQ:FATE).
Molecular Partners has a consensus price target of $8.17.
The stock price for Molecular Partners (NASDAQ: MOLN) is $4.15 last updated April 24, 2025 at 11:07 AM EDT.
There are no upcoming dividends for Molecular Partners.
Molecular Partners’s FY earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Molecular Partners.
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.